| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Bupropion measurement |
Component |
True |
Bupropion (substance) |
Inferred relationship |
Some |
1 |
| Bupropion m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupropion (substance) |
Inferred relationship |
Some |
|
| Bupropion hydrochloride (substance) |
Is a |
False |
Bupropion (substance) |
Inferred relationship |
Some |
|
| Product containing bupropion (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupropion (substance) |
Inferred relationship |
Some |
1 |
| Adverse reaction to bupropion |
Causative agent (attribute) |
True |
Bupropion (substance) |
Inferred relationship |
Some |
1 |
| Bupropion hydrobromide (substance) |
Is a |
False |
Bupropion (substance) |
Inferred relationship |
Some |
|
| Product containing bupropion and naltrexone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupropion (substance) |
Inferred relationship |
Some |
2 |
| Product containing bupropion and naltrexone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupropion (substance) |
Inferred relationship |
Some |
2 |
| Bupropion therapy (procedure) |
Direct substance |
True |
Bupropion (substance) |
Inferred relationship |
Some |
2 |
| Bupropion hydrobromide (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Bupropion (substance) |
Inferred relationship |
Some |
|
| Bupropion hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Bupropion (substance) |
Inferred relationship |
Some |
|
| Bupropion hydrochloride 50mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupropion (substance) |
Inferred relationship |
Some |
|
| Bupropion hydrochloride 300mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupropion (substance) |
Inferred relationship |
Some |
|
| Bupropion hydrochloride 200mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bupropion (substance) |
Inferred relationship |
Some |
|
| Bupropion-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupropion (substance) |
Inferred relationship |
Some |
1 |
| Product containing only bupropion (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupropion (substance) |
Inferred relationship |
Some |
1 |
| Product containing only bupropion and naltrexone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupropion (substance) |
Inferred relationship |
Some |
2 |
| Bupropion and naltrexone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupropion (substance) |
Inferred relationship |
Some |
2 |
| Product containing only bupropion in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bupropion (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]